Macrophage Activation Syndrome Secondary to Human Monocytic Ehrlichiosis

Indian Journal of Hematology and Blood Transfusion

Volumn 30, Issue , 2014, Pages 145-147

  Kumar, Nilay ^a   Goyal, Jatinder ^a   Goel, Anshum ^a   Shakoory, Bita ^b   Chatham, Winn ^b  

^a University of Alabama at Birmingham   (United States)

^b The University of Alabama at Birmingham   (United States)

Author keywords

Anakinra; Ehrlichiosis; Hemophagocytic lymphohistiocytosis; Immunosuppressive agents; Macrophage activation syndrome

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CEFTAZIDIME; CREATININE; DOXYCYCLINE; FERRITIN; FIBRINOGEN; HEMOGLOBIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LACTATE DEHYDROGENASE; METHYLPREDNISOLONE; MYCOPHENOLATE MOFETIL; PREDNISONE; RAPAMYCIN; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; TRIACYLGLYCEROL; VANCOMYCIN;

ADULT; ANTIBODY TITER; ARTICLE; BLOOD SMEAR; CASE REPORT; DISORIENTATION; DRUG DOSE REDUCTION; DRUG MEGADOSE; EHRLICHIA CHAFFEENSIS; FEVER; HEMOPHAGOCYTIC SYNDROME; HEPATOSPLENOMEGALY; HUMAN; HUMAN MONOCYTIC EHRLICHIOSIS; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DYSFUNCTION; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LEUKOCYTE COUNT; MACROPHAGE ACTIVATION SYNDROME; MAINTENANCE THERAPY; MALE; MEDICAL HISTORY; MENTAL INSTABILITY; NEUTROPHIL COUNT; NON INSULIN DEPENDENT DIABETES MELLITUS; PARTIAL THROMBOPLASTIN TIME; PETECHIA; POLYMERASE CHAIN REACTION; PROTHROMBIN TIME; SEPSIS; SEROLOGY; SOMNOLENCE; THROMBOCYTE COUNT; UREA NITROGEN BLOOD LEVEL;

EID: 84924812282     PISSN: 09714502     EISSN: 09740449     Source Type: Journal    
DOI: 10.1007/s12288-013-0299-3     Document Type: Article

References (9)

1. Henter JI, Horne A, Arico M, Egeler RM, Filipovich AH, Imashuku S, Ladisch S, McClain K, Webb D, Winiarski J, Janka G (2007) HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 48(2):124–131. doi:10.1002/pbc.21039
2. Jordan MB, Allen CE, Weitzman S, Filipovich AH, McClain KL (2011) How I treat hemophagocytic lymphohistiocytosis. Blood 118(15):4041–4052. doi:10.1182/blood-2011-03-278127
3. Dumler JS, Madigan JE, Pusterla N, Bakken JS (2007) Ehrlichioses in humans: epidemiology, clinical presentation, diagnosis, and treatment. Clin Infect Dis 45(1):S45–S51. doi:10.1086/518146
4. Martin GS, Christman BW, Standaert SM (1999) Rapidly fatal infection with Ehrlichia chaffeensis. N Engl J Med 341(10):763–764. doi:10.1056/NEJM199909023411014
5. Peters TR, Edwards KM, Standaert SM (2000) Severe ehrlichiosis in an adolescent taking trimethoprim-sulfamethoxazole. Pediatr Infect Dis J 19(2):170–172
6. Burns S, Saylors R, Mian A (2010) Hemophagocytic lymphohistiocytosis secondary to Ehrlichia chaffeensis infection: a case report. J Pediatr Hematol Oncol 32(4):e142–e143. doi:10.1097/MPH.0b013e3181c80ab9
7. Hanson D, Walter AW, Powell J (2011) Ehrlichia-induced hemophagocytic lymphohistiocytosis in two children. Pediatr Blood Cancer 56(4):661–663. doi:10.1002/pbc.22814
8. Behrens EM, Kreiger PA, Cherian S, Cron RQ (2006) Interleukin 1 receptor antagonist to treat cytophagic histiocytic panniculitis with secondary hemophagocytic lymphohistiocytosis. J Rheumatol 33(10):2081–2084 0315162X-33-2081
9. Bruck N, Suttorp M, Kabus M, Heubner G, Gahr M, Pessler F (2011) Rapid and sustained remission of systemic juvenile idiopathic arthritis-associated macrophage activation syndrome through treatment with anakinra and corticosteroids. J Clin Rheumatol 17(1):23–27. doi:10.1097/RHU.0b013e318205092d